Eligo Bioscience
Business Services · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
111 Avenue De France, Paris, Ile-de-Fran...Website
eligo.bioRevenue
$6.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Eligo Bioscience
Eligo Bioscience is focused on in vivo gene editing technologies targeting the microbiome for diseases with high unmet needs. Their GEM (Gene Editing of the Microbiome) platform allows editing of the microbiome gene repertoire in vivo. Led by renowned scientists, Eligo Bioscience aims to revolutionize healthcare through precise editing of bacterial genes associated with various diseases.Explore more
Eligo Bioscience Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Eligo Bioscience your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Eligo Bioscience launches new products
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Eligo Bioscience
Check if Eligo Bioscience has recently received funding, and reach out quickly before it becomes old news!
Check out if Eligo Bioscience is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Eligo Bioscience, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Eligo Bioscience had a recent Job posting/layoffs
Earning: See what the market has to say on Eligo Bioscience recently announced quarterly report
Funding: Get notified immidiatlly once Eligo Bioscience has new funding data
Recommended Actions
Find VP level buyers at Eligo Bioscience
Find 3 more new buyers
Company Profile Activity
Activity Insights
Eligo Bioscience is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Eligo Bioscience is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Eligo Bioscience.
Eligo Bioscience financials insights
Gather financial insights about Eligo Bioscience, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Series A
$20M
2023
Series B
$30M
2025
Grant
$5M
Eligo Bioscience Tech Stack
A closer look at the technologies used by Eligo Bioscience
Most Recent Scoops
Hiring Plans
Eligo Bioscience is hiring in Medical & Health for the first time in 12 months. Areas of expertise include: Drug Discovery, Experimental Design and Execution, Pharmacology, Molecular Biology, Immunology, Cell Cultures, and Microbiology.
Hiring Plans
Open Position
Funding
Funding
Open Position
Open Position
Eligo Bioscience News & Media
Eligo Bioscience Awarded $5 Million to Advance Breakthrough Genetic Medicine Platform for Immuno-Dermatology
Funding is part of the call for proposals "Innovations in Biotherapies and Bioproduction," coordinated by the Health Innovation Agency under France 2030 strategy, operated on behalf of the French government by Bpifrance PARIS, May 13, 2025 /PRNewswire/ -- Eligo Bioscience, a biotechnology company pioneering the development of novel genetic medicines, today announced it has secured a $5 million grant from the French government to accelerate the advancement and scaling up of Eligo's proprietary toEligo Publishes in Nature a Landmark Study That Unlocks Genome Editing of Bacteria in the Gut
PARIS, July 10, 2024 /PRNewswire/ -- For the first time, a team of scientists at Eligo has demonstrated it was possible to genetically modify bacteria with nearly 100% efficiency directly in the gut of animals. This work provides scientists with a novel strategy to better understand how...Eligo Publishes in Nature a Landmark Study That Unlocks Genome Editing of Bacteria in the Gut
PARIS, July 10, 2024 /PRNewswire/ -- For the first time, a team of scientists at Eligo has demonstrated it was possible to genetically modify bacteria with nearly 100% efficiency directly in the gut of animals. This work provides scientists with a novel strategy to better understand how...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Eligo Bioscience
Sign Up For FreeTo access detailed company insights
Eligo Bioscience is focused on in vivo gene editing technologies targeting the microbiome for diseases with high unmet needs. Their GEM (Gene Editing of the Microbiome) platform allows editing of the microbiome gene repertoire in vivo. Led by renowned scientists, Eligo Bioscience aims to revolutionize healthcare through precise editing of bacterial... Read More
